Subnetwork | Dataset | Score | p-value 1 | p-value 2 | p-value 3 | Size | Highlighted genes |
---|---|---|---|---|---|---|---|
reg-snw-60 | tai-screen-luciferase | 4.243 | 1.88e-19 | 3.43e-03 | 4.71e-03 | 12 | 5 |
int-snw-112950 | tai-screen-luciferase | 6.537 | 1.50e-144 | 1.20e-07 | 1.60e-03 | 9 | 6 |
Gene Symbol | Entrez Gene ID | Frequency | tai-screen-luciferase gene score | Best subnetwork score | Degree | List-Gonzales GI | Tai-Hits |
---|---|---|---|---|---|---|---|
HES4 | 57801 | 19 | -4.153 | 4.450 | 10 | - | - |
DMD | 1756 | 15 | -4.338 | 4.243 | 53 | - | - |
COPA | 1314 | 48 | -9.395 | 5.672 | 340 | Yes | Yes |
TNFRSF8 | 943 | 19 | -4.106 | 4.450 | 15 | - | - |
HSF1 | 3297 | 46 | -4.179 | 5.027 | 209 | - | Yes |
CANX | 821 | 17 | -1.959 | 4.504 | 65 | - | - |
COPB2 | 9276 | 48 | -13.168 | 9.063 | 41 | Yes | Yes |
SNTA1 | 6640 | 2 | 2.065 | 6.537 | 73 | - | - |
COPZ1 | 22818 | 48 | -8.301 | 9.063 | 13 | Yes | Yes |
RB1 | 5925 | 21 | -2.085 | 4.707 | 351 | - | - |
CDC42 | 998 | 44 | -6.960 | 4.707 | 276 | Yes | Yes |
MED8 | 112950 | 2 | 1.834 | 6.537 | 42 | - | - |
MRPS12 | 6183 | 35 | -5.421 | 5.516 | 341 | Yes | - |
SRF | 6722 | 15 | 1.994 | 4.243 | 23 | - | - |
ACTB | 60 | 15 | -1.716 | 4.243 | 23 | - | - |
ARCN1 | 372 | 48 | -8.232 | 9.063 | 118 | Yes | Yes |
SERBP1 | 26135 | 35 | -4.612 | 5.516 | 106 | - | Yes |
COPB1 | 1315 | 39 | -6.221 | 9.063 | 118 | Yes | Yes |
COPG1 | 22820 | 12 | -5.279 | 7.138 | 37 | Yes | Yes |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
TNFRSF8 | 943 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
ARCN1 | 372 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, Tarassov_PCA, YeastMedium, INTEROLOG |
COPZ1 | 22818 | COPG1 | 22820 | pp | -- | int.I2D: BioGrid, HPRD, BIND; int.HPRD: in vitro, in vivo, yeast 2-hybrid; int.DIP: MI:0915(physical association) |
ACTB | 60 | CANX | 821 | pd | < | reg.ITFP.txt: no annot |
COPA | 1314 | RB1 | 5925 | pd | <> | reg.ITFP.txt: no annot |
HSF1 | 3297 | SRF | 6722 | pd | <> | reg.ITFP.txt: no annot |
HSF1 | 3297 | SRF | 6722 | pp | -- | int.Yu: muscle |
COPB2 | 9276 | COPG1 | 22820 | pp | -- | int.I2D: BioGrid |
RB1 | 5925 | HES4 | 57801 | pd | > | reg.pazar.txt: no annot |
RB1 | 5925 | SERBP1 | 26135 | pd | > | reg.pazar.txt: no annot |
ACTB | 60 | MRPS12 | 6183 | pp | -- | int.I2D: BioGrid_Yeast |
SNTA1 | 6640 | MED8 | 112950 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: HPRD, MINT, StelzlLow, IntAct; int.Mint: MI:0915(physical association); int.HPRD: yeast 2-hybrid |
ARCN1 | 372 | COPG1 | 22820 | pp | -- | int.I2D: HPRD; int.HPRD: in vivo |
DMD | 1756 | MED8 | 112950 | pp | -- | int.I2D: BioGrid_Fly, FlyLow, IntAct_Fly |
COPB1 | 1315 | COPG1 | 22820 | pp | -- | int.I2D: BioGrid, HPRD; int.HPRD: in vitro, in vivo, yeast 2-hybrid; int.DIP: MI:0915(physical association) |
COPB1 | 1315 | SNTA1 | 6640 | pp | -- | int.I2D: INNATEDB |
DMD | 1756 | SNTA1 | 6640 | pp | -- | int.I2D: BCI, BioGrid, BIND_Mouse, HPRD, IntAct_Mouse, MINT_Mouse; int.HPRD: in vitro, in vivo |
ACTB | 60 | RB1 | 5925 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | COPA | 1314 | pd | < | reg.ITFP.txt: no annot |
ACTB | 60 | COPA | 1314 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | COPB1 | 1315 | pp | -- | int.I2D: BioGrid, BioGrid_Yeast, BIND_Yeast, IntAct_Yeast, MINT_Yeast, Krogan_Core, YeastHigh |
DMD | 1756 | SRF | 6722 | pd | < | reg.pazar.txt: no annot; reg.TRANSFAC.txt: no annot |
CANX | 821 | RB1 | 5925 | pd | <> | reg.ITFP.txt: no annot |
COPA | 1314 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastMedium |
CANX | 821 | MRPS12 | 6183 | pp | -- | int.I2D: BioGrid_Yeast |
COPA | 1314 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid, HPRD, BCI; int.HPRD: in vivo |
COPB1 | 1315 | COPZ1 | 22818 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastMedium; int.DIP: MI:0915(physical association) |
CANX | 821 | COPA | 1314 | pd | <> | reg.ITFP.txt: no annot |
ACTB | 60 | ARCN1 | 372 | pp | -- | int.I2D: BioGrid_Yeast |
HSF1 | 3297 | MRPS12 | 6183 | pd | <> | reg.ITFP.txt: no annot |
RB1 | 5925 | MED8 | 112950 | pd | > | reg.pazar.txt: no annot |
COPB1 | 1315 | COPB2 | 9276 | pp | -- | int.I2D: BioGrid |
ARCN1 | 372 | COPB1 | 1315 | pp | -- | int.I2D: BCI, BioGrid, BioGrid_Yeast, IntAct_Yeast, INTEROLOG, MINT_Yeast, YeastHigh, BIND, BIND_Yeast, HPRD, Krogan_Core, MIPS; int.HPRD: in vivo |
ARCN1 | 372 | COPA | 1314 | pp | -- | int.I2D: BCI, BioGrid_Yeast, IntAct_Yeast, MINT_Yeast, YeastHigh, HPRD, Krogan_Core; int.HPRD: in vivo |
CDC42 | 998 | RB1 | 5925 | pd | < | reg.pazar.txt: no annot |
ARCN1 | 372 | COPB2 | 9276 | pp | -- | int.I2D: HPRD, BCI; int.HPRD: in vivo |
ACTB | 60 | SRF | 6722 | pd | < | reg.pazar.txt: no annot; reg.oreganno.txt: no annot |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0048205 | COPI coating of Golgi vesicle | 1.77e-15 | 2.88e-11 | 8.631 | 6 | 6 | 13 |
GO:0030126 | COPI vesicle coat | 1.77e-15 | 2.88e-11 | 8.631 | 6 | 6 | 13 |
GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER | 1.81e-13 | 2.95e-09 | 7.688 | 6 | 6 | 25 |
GO:0061024 | membrane organization | 1.83e-10 | 2.98e-06 | 5.364 | 7 | 11 | 146 |
GO:0006886 | intracellular protein transport | 3.15e-08 | 5.14e-04 | 4.897 | 6 | 6 | 173 |
GO:0050998 | nitric-oxide synthase binding | 7.42e-07 | 1.21e-02 | 7.331 | 3 | 3 | 16 |
GO:0006891 | intra-Golgi vesicle-mediated transport | 9.00e-07 | 1.47e-02 | 7.244 | 3 | 3 | 17 |
GO:0051683 | establishment of Golgi localization | 3.85e-06 | 6.28e-02 | 9.162 | 2 | 2 | 3 |
GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation | 3.85e-06 | 6.28e-02 | 9.162 | 2 | 2 | 3 |
GO:0016013 | syntrophin complex | 7.69e-06 | 1.26e-01 | 8.747 | 2 | 2 | 4 |
GO:0072384 | organelle transport along microtubule | 7.69e-06 | 1.26e-01 | 8.747 | 2 | 2 | 4 |
GO:0043234 | protein complex | 1.91e-05 | 3.12e-01 | 3.840 | 5 | 9 | 300 |
GO:0005198 | structural molecule activity | 3.00e-05 | 4.90e-01 | 4.434 | 4 | 5 | 159 |
GO:0090136 | epithelial cell-cell adhesion | 4.60e-05 | 7.51e-01 | 7.577 | 2 | 2 | 9 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 2.93e-04 | 1.00e+00 | 6.287 | 2 | 5 | 22 |
GO:0002027 | regulation of heart rate | 5.48e-04 | 1.00e+00 | 5.840 | 2 | 2 | 30 |
GO:0034332 | adherens junction organization | 7.90e-04 | 1.00e+00 | 5.577 | 2 | 4 | 36 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 9.20e-04 | 1.00e+00 | 3.939 | 3 | 4 | 168 |
GO:0030038 | contractile actin filament bundle assembly | 1.16e-03 | 1.00e+00 | 9.747 | 1 | 1 | 1 |
GO:0045556 | positive regulation of TRAIL biosynthetic process | 1.16e-03 | 1.00e+00 | 9.747 | 1 | 1 | 1 |
GO:0090287 | regulation of cellular response to growth factor stimulus | 1.16e-03 | 1.00e+00 | 9.747 | 1 | 1 | 1 |
GO:0021691 | cerebellar Purkinje cell layer maturation | 1.16e-03 | 1.00e+00 | 9.747 | 1 | 1 | 1 |
GO:0090230 | regulation of centromere complex assembly | 1.16e-03 | 1.00e+00 | 9.747 | 1 | 1 | 1 |
GO:0046016 | positive regulation of transcription by glucose | 1.16e-03 | 1.00e+00 | 9.747 | 1 | 1 | 1 |
GO:0003117 | regulation of vasoconstriction by circulating norepinephrine | 1.16e-03 | 1.00e+00 | 9.747 | 1 | 1 | 1 |
GO:0005829 | cytosol | 1.17e-03 | 1.00e+00 | 1.593 | 9 | 74 | 2562 |
GO:0034613 | cellular protein localization | 1.18e-03 | 1.00e+00 | 5.287 | 2 | 2 | 44 |
GO:0021762 | substantia nigra development | 1.29e-03 | 1.00e+00 | 5.223 | 2 | 2 | 46 |
GO:0016328 | lateral plasma membrane | 1.29e-03 | 1.00e+00 | 5.223 | 2 | 3 | 46 |
GO:0030175 | filopodium | 1.71e-03 | 1.00e+00 | 5.019 | 2 | 2 | 53 |
GO:0071338 | positive regulation of hair follicle cell proliferation | 2.33e-03 | 1.00e+00 | 8.747 | 1 | 1 | 2 |
GO:0060661 | submandibular salivary gland formation | 2.33e-03 | 1.00e+00 | 8.747 | 1 | 1 | 2 |
GO:0090135 | actin filament branching | 2.33e-03 | 1.00e+00 | 8.747 | 1 | 1 | 2 |
GO:0014819 | regulation of skeletal muscle contraction | 2.33e-03 | 1.00e+00 | 8.747 | 1 | 1 | 2 |
GO:0031134 | sister chromatid biorientation | 2.33e-03 | 1.00e+00 | 8.747 | 1 | 1 | 2 |
GO:0086001 | cardiac muscle cell action potential | 2.33e-03 | 1.00e+00 | 8.747 | 1 | 1 | 2 |
GO:0010736 | serum response element binding | 2.33e-03 | 1.00e+00 | 8.747 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 2.33e-03 | 1.00e+00 | 8.747 | 1 | 1 | 2 |
GO:0016020 | membrane | 2.50e-03 | 1.00e+00 | 1.784 | 7 | 48 | 1746 |
GO:0008134 | transcription factor binding | 2.74e-03 | 1.00e+00 | 3.389 | 3 | 5 | 246 |
GO:0042383 | sarcolemma | 3.04e-03 | 1.00e+00 | 4.597 | 2 | 2 | 71 |
GO:0031175 | neuron projection development | 3.39e-03 | 1.00e+00 | 4.518 | 2 | 2 | 75 |
GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 3 |
GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 3 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 3 |
GO:0060947 | cardiac vascular smooth muscle cell differentiation | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 3 |
GO:0003161 | cardiac conduction system development | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 3 |
GO:0071459 | protein localization to chromosome, centromeric region | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 3 |
GO:0033561 | regulation of water loss via skin | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 3 |
GO:1900222 | negative regulation of beta-amyloid clearance | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 3 |
GO:1901385 | regulation of voltage-gated calcium channel activity | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 3 |
GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle | 3.49e-03 | 1.00e+00 | 8.162 | 1 | 1 | 3 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 3.57e-03 | 1.00e+00 | 4.480 | 2 | 4 | 77 |
GO:0071922 | regulation of cohesin localization to chromatin | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 2 | 4 |
GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 1 | 4 |
GO:0034191 | apolipoprotein A-I receptor binding | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 1 | 4 |
GO:0048664 | neuron fate determination | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 1 | 4 |
GO:0010669 | epithelial structure maintenance | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 1 | 4 |
GO:0010735 | positive regulation of transcription via serum response element binding | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 1 | 4 |
GO:0060684 | epithelial-mesenchymal cell signaling | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 1 | 4 |
GO:0051835 | positive regulation of synapse structural plasticity | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 1 | 4 |
GO:0043550 | regulation of lipid kinase activity | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 1 | 4 |
GO:0035189 | Rb-E2F complex | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 1 | 4 |
GO:0034349 | glial cell apoptotic process | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 1 | 4 |
GO:0034088 | maintenance of mitotic sister chromatid cohesion | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 1 | 4 |
GO:0090231 | regulation of spindle checkpoint | 4.65e-03 | 1.00e+00 | 7.747 | 1 | 1 | 4 |
GO:0005200 | structural constituent of cytoskeleton | 5.16e-03 | 1.00e+00 | 4.207 | 2 | 6 | 93 |
GO:0005856 | cytoskeleton | 5.29e-03 | 1.00e+00 | 3.051 | 3 | 6 | 311 |
GO:0036336 | dendritic cell migration | 5.81e-03 | 1.00e+00 | 7.425 | 1 | 1 | 5 |
GO:0043043 | peptide biosynthetic process | 5.81e-03 | 1.00e+00 | 7.425 | 1 | 1 | 5 |
GO:2000651 | positive regulation of sodium ion transmembrane transporter activity | 5.81e-03 | 1.00e+00 | 7.425 | 1 | 1 | 5 |
GO:0035088 | establishment or maintenance of apical/basal cell polarity | 5.81e-03 | 1.00e+00 | 7.425 | 1 | 1 | 5 |
GO:0048667 | cell morphogenesis involved in neuron differentiation | 5.81e-03 | 1.00e+00 | 7.425 | 1 | 1 | 5 |
GO:0031256 | leading edge membrane | 5.81e-03 | 1.00e+00 | 7.425 | 1 | 1 | 5 |
GO:0044233 | ER-mitochondrion membrane contact site | 5.81e-03 | 1.00e+00 | 7.425 | 1 | 1 | 5 |
GO:0035912 | dorsal aorta morphogenesis | 5.81e-03 | 1.00e+00 | 7.425 | 1 | 1 | 5 |
GO:0005515 | protein binding | 6.22e-03 | 1.00e+00 | 0.866 | 13 | 87 | 6127 |
GO:0043353 | enucleate erythrocyte differentiation | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 6 |
GO:0007143 | female meiotic division | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 6 |
GO:0044458 | motile cilium assembly | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 6 |
GO:0045842 | positive regulation of mitotic metaphase/anaphase transition | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 6 |
GO:0051150 | regulation of smooth muscle cell differentiation | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 6 |
GO:0060789 | hair follicle placode formation | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 6 |
GO:0030957 | Tat protein binding | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 6 |
GO:0048554 | positive regulation of metalloenzyme activity | 6.97e-03 | 1.00e+00 | 7.162 | 1 | 1 | 6 |
GO:0005737 | cytoplasm | 7.31e-03 | 1.00e+00 | 1.111 | 10 | 65 | 3976 |
GO:0007097 | nuclear migration | 8.12e-03 | 1.00e+00 | 6.939 | 1 | 2 | 7 |
GO:0003334 | keratinocyte development | 8.12e-03 | 1.00e+00 | 6.939 | 1 | 1 | 7 |
GO:0051988 | regulation of attachment of spindle microtubules to kinetochore | 8.12e-03 | 1.00e+00 | 6.939 | 1 | 1 | 7 |
GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter | 8.12e-03 | 1.00e+00 | 6.939 | 1 | 1 | 7 |
GO:0002162 | dystroglycan binding | 8.12e-03 | 1.00e+00 | 6.939 | 1 | 1 | 7 |
GO:0060055 | angiogenesis involved in wound healing | 8.12e-03 | 1.00e+00 | 6.939 | 1 | 1 | 7 |
GO:0030157 | pancreatic juice secretion | 8.12e-03 | 1.00e+00 | 6.939 | 1 | 1 | 7 |
GO:0060136 | embryonic process involved in female pregnancy | 8.12e-03 | 1.00e+00 | 6.939 | 1 | 1 | 7 |
GO:1902305 | regulation of sodium ion transmembrane transport | 8.12e-03 | 1.00e+00 | 6.939 | 1 | 1 | 7 |
GO:0043497 | regulation of protein heterodimerization activity | 8.12e-03 | 1.00e+00 | 6.939 | 1 | 1 | 7 |
GO:0008285 | negative regulation of cell proliferation | 8.36e-03 | 1.00e+00 | 2.812 | 3 | 3 | 367 |
GO:0043589 | skin morphogenesis | 9.28e-03 | 1.00e+00 | 6.747 | 1 | 1 | 8 |
GO:0090009 | primitive streak formation | 9.28e-03 | 1.00e+00 | 6.747 | 1 | 1 | 8 |
GO:0070688 | MLL5-L complex | 9.28e-03 | 1.00e+00 | 6.747 | 1 | 1 | 8 |
GO:0051489 | regulation of filopodium assembly | 9.28e-03 | 1.00e+00 | 6.747 | 1 | 1 | 8 |
GO:0000790 | nuclear chromatin | 1.03e-02 | 1.00e+00 | 3.691 | 2 | 2 | 133 |
GO:0097284 | hepatocyte apoptotic process | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 9 |
GO:0000983 | RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 9 |
GO:0000075 | cell cycle checkpoint | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 9 |
GO:0045059 | positive thymic T cell selection | 1.04e-02 | 1.00e+00 | 6.577 | 1 | 1 | 9 |
GO:0000139 | Golgi membrane | 1.12e-02 | 1.00e+00 | 2.659 | 3 | 7 | 408 |
GO:0031274 | positive regulation of pseudopodium assembly | 1.16e-02 | 1.00e+00 | 6.425 | 1 | 2 | 10 |
GO:0001076 | RNA polymerase II transcription factor binding transcription factor activity | 1.16e-02 | 1.00e+00 | 6.425 | 1 | 1 | 10 |
GO:0061029 | eyelid development in camera-type eye | 1.16e-02 | 1.00e+00 | 6.425 | 1 | 1 | 10 |
GO:0005798 | Golgi-associated vesicle | 1.16e-02 | 1.00e+00 | 6.425 | 1 | 1 | 10 |
GO:0060218 | hematopoietic stem cell differentiation | 1.16e-02 | 1.00e+00 | 6.425 | 1 | 1 | 10 |
GO:0060047 | heart contraction | 1.16e-02 | 1.00e+00 | 6.425 | 1 | 1 | 10 |
GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process | 1.16e-02 | 1.00e+00 | 6.425 | 1 | 1 | 10 |
GO:0017166 | vinculin binding | 1.27e-02 | 1.00e+00 | 6.287 | 1 | 1 | 11 |
GO:0042551 | neuron maturation | 1.27e-02 | 1.00e+00 | 6.287 | 1 | 1 | 11 |
GO:0045651 | positive regulation of macrophage differentiation | 1.27e-02 | 1.00e+00 | 6.287 | 1 | 1 | 11 |
GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization | 1.27e-02 | 1.00e+00 | 6.287 | 1 | 1 | 11 |
GO:0045120 | pronucleus | 1.27e-02 | 1.00e+00 | 6.287 | 1 | 1 | 11 |
GO:0002011 | morphogenesis of an epithelial sheet | 1.27e-02 | 1.00e+00 | 6.287 | 1 | 1 | 11 |
GO:0006457 | protein folding | 1.28e-02 | 1.00e+00 | 3.527 | 2 | 3 | 149 |
GO:0072583 | clathrin-mediated endocytosis | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 12 |
GO:0051146 | striated muscle cell differentiation | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 2 | 12 |
GO:0043149 | stress fiber assembly | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 2 | 12 |
GO:0055003 | cardiac myofibril assembly | 1.39e-02 | 1.00e+00 | 6.162 | 1 | 1 | 12 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 1.50e-02 | 1.00e+00 | 6.046 | 1 | 1 | 13 |
GO:0043488 | regulation of mRNA stability | 1.50e-02 | 1.00e+00 | 6.046 | 1 | 1 | 13 |
GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity | 1.50e-02 | 1.00e+00 | 6.046 | 1 | 1 | 13 |
GO:0035855 | megakaryocyte development | 1.50e-02 | 1.00e+00 | 6.046 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 1.62e-02 | 1.00e+00 | 5.939 | 1 | 2 | 14 |
GO:0031333 | negative regulation of protein complex assembly | 1.62e-02 | 1.00e+00 | 5.939 | 1 | 1 | 14 |
GO:0031996 | thioesterase binding | 1.62e-02 | 1.00e+00 | 5.939 | 1 | 1 | 14 |
GO:0034185 | apolipoprotein binding | 1.62e-02 | 1.00e+00 | 5.939 | 1 | 1 | 14 |
GO:0060292 | long term synaptic depression | 1.62e-02 | 1.00e+00 | 5.939 | 1 | 1 | 14 |
GO:0048488 | synaptic vesicle endocytosis | 1.62e-02 | 1.00e+00 | 5.939 | 1 | 1 | 14 |
GO:0030424 | axon | 1.68e-02 | 1.00e+00 | 3.320 | 2 | 4 | 172 |
GO:0045445 | myoblast differentiation | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 15 |
GO:0048821 | erythrocyte development | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 2 | 15 |
GO:0030131 | clathrin adaptor complex | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 15 |
GO:0002042 | cell migration involved in sprouting angiogenesis | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 15 |
GO:0030225 | macrophage differentiation | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 15 |
GO:0016010 | dystrophin-associated glycoprotein complex | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 15 |
GO:0016514 | SWI/SNF complex | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 15 |
GO:0051233 | spindle midzone | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 2 | 15 |
GO:0045987 | positive regulation of smooth muscle contraction | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 15 |
GO:0060347 | heart trabecula formation | 1.73e-02 | 1.00e+00 | 5.840 | 1 | 1 | 15 |
GO:0045211 | postsynaptic membrane | 1.77e-02 | 1.00e+00 | 3.279 | 2 | 3 | 177 |
GO:0032839 | dendrite cytoplasm | 1.85e-02 | 1.00e+00 | 5.747 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 1.85e-02 | 1.00e+00 | 5.747 | 1 | 4 | 16 |
GO:0033137 | negative regulation of peptidyl-serine phosphorylation | 1.85e-02 | 1.00e+00 | 5.747 | 1 | 1 | 16 |
GO:0030220 | platelet formation | 1.85e-02 | 1.00e+00 | 5.747 | 1 | 1 | 16 |
GO:0043623 | cellular protein complex assembly | 1.85e-02 | 1.00e+00 | 5.747 | 1 | 1 | 16 |
GO:0046716 | muscle cell cellular homeostasis | 1.85e-02 | 1.00e+00 | 5.747 | 1 | 1 | 16 |
GO:0031527 | filopodium membrane | 1.96e-02 | 1.00e+00 | 5.659 | 1 | 1 | 17 |
GO:0001829 | trophectodermal cell differentiation | 1.96e-02 | 1.00e+00 | 5.659 | 1 | 1 | 17 |
GO:0035255 | ionotropic glutamate receptor binding | 1.96e-02 | 1.00e+00 | 5.659 | 1 | 1 | 17 |
GO:0086005 | ventricular cardiac muscle cell action potential | 1.96e-02 | 1.00e+00 | 5.659 | 1 | 1 | 17 |
GO:0015935 | small ribosomal subunit | 1.96e-02 | 1.00e+00 | 5.659 | 1 | 9 | 17 |
GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum | 1.96e-02 | 1.00e+00 | 5.659 | 1 | 1 | 17 |
GO:0030742 | GTP-dependent protein binding | 1.96e-02 | 1.00e+00 | 5.659 | 1 | 1 | 17 |
GO:0008306 | associative learning | 1.96e-02 | 1.00e+00 | 5.659 | 1 | 1 | 17 |
GO:0017022 | myosin binding | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 2 | 18 |
GO:0090316 | positive regulation of intracellular protein transport | 2.08e-02 | 1.00e+00 | 5.577 | 1 | 1 | 18 |
GO:0007088 | regulation of mitosis | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 19 |
GO:0010881 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 19 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 2.30e-02 | 1.00e+00 | 5.425 | 1 | 1 | 20 |
GO:0090398 | cellular senescence | 2.30e-02 | 1.00e+00 | 5.425 | 1 | 1 | 20 |
GO:0043473 | pigmentation | 2.30e-02 | 1.00e+00 | 5.425 | 1 | 2 | 20 |
GO:0046847 | filopodium assembly | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 21 |
GO:0009306 | protein secretion | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 2 | 21 |
GO:0043034 | costamere | 2.42e-02 | 1.00e+00 | 5.354 | 1 | 1 | 21 |
GO:0005790 | smooth endoplasmic reticulum | 2.53e-02 | 1.00e+00 | 5.287 | 1 | 1 | 22 |
GO:0031435 | mitogen-activated protein kinase kinase kinase binding | 2.53e-02 | 1.00e+00 | 5.287 | 1 | 1 | 22 |
GO:0017080 | sodium channel regulator activity | 2.53e-02 | 1.00e+00 | 5.287 | 1 | 1 | 22 |
GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle | 2.53e-02 | 1.00e+00 | 5.287 | 1 | 1 | 22 |
GO:0030863 | cortical cytoskeleton | 2.53e-02 | 1.00e+00 | 5.287 | 1 | 1 | 22 |
GO:0001892 | embryonic placenta development | 2.65e-02 | 1.00e+00 | 5.223 | 1 | 1 | 23 |
GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading | 2.65e-02 | 1.00e+00 | 5.223 | 1 | 1 | 23 |
GO:0051491 | positive regulation of filopodium assembly | 2.65e-02 | 1.00e+00 | 5.223 | 1 | 2 | 23 |
GO:0043044 | ATP-dependent chromatin remodeling | 2.65e-02 | 1.00e+00 | 5.223 | 1 | 1 | 23 |
GO:0002040 | sprouting angiogenesis | 2.65e-02 | 1.00e+00 | 5.223 | 1 | 1 | 23 |
GO:0045879 | negative regulation of smoothened signaling pathway | 2.65e-02 | 1.00e+00 | 5.223 | 1 | 1 | 23 |
GO:0051017 | actin filament bundle assembly | 2.65e-02 | 1.00e+00 | 5.223 | 1 | 1 | 23 |
GO:0005761 | mitochondrial ribosome | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 1 | 24 |
GO:0007163 | establishment or maintenance of cell polarity | 2.76e-02 | 1.00e+00 | 5.162 | 1 | 2 | 24 |
GO:0048589 | developmental growth | 2.99e-02 | 1.00e+00 | 5.046 | 1 | 1 | 26 |
GO:0001707 | mesoderm formation | 2.99e-02 | 1.00e+00 | 5.046 | 1 | 1 | 26 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 2.99e-02 | 1.00e+00 | 5.046 | 1 | 2 | 26 |
GO:0071556 | integral component of lumenal side of endoplasmic reticulum membrane | 2.99e-02 | 1.00e+00 | 5.046 | 1 | 1 | 26 |
GO:0045214 | sarcomere organization | 2.99e-02 | 1.00e+00 | 5.046 | 1 | 1 | 26 |
GO:0045859 | regulation of protein kinase activity | 2.99e-02 | 1.00e+00 | 5.046 | 1 | 1 | 26 |
GO:0031424 | keratinization | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 27 |
GO:0051149 | positive regulation of muscle cell differentiation | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 2 | 27 |
GO:0032720 | negative regulation of tumor necrosis factor production | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 27 |
GO:0007616 | long-term memory | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 27 |
GO:0048565 | digestive tract development | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 27 |
GO:0031069 | hair follicle morphogenesis | 3.10e-02 | 1.00e+00 | 4.992 | 1 | 1 | 27 |
GO:0032467 | positive regulation of cytokinesis | 3.21e-02 | 1.00e+00 | 4.939 | 1 | 1 | 28 |
GO:0045597 | positive regulation of cell differentiation | 3.21e-02 | 1.00e+00 | 4.939 | 1 | 1 | 28 |
GO:0031492 | nucleosomal DNA binding | 3.21e-02 | 1.00e+00 | 4.939 | 1 | 1 | 28 |
GO:0019894 | kinesin binding | 3.21e-02 | 1.00e+00 | 4.939 | 1 | 1 | 28 |
GO:0044822 | poly(A) RNA binding | 3.31e-02 | 1.00e+00 | 1.672 | 4 | 42 | 1078 |
GO:0003730 | mRNA 3'-UTR binding | 3.32e-02 | 1.00e+00 | 4.889 | 1 | 1 | 29 |
GO:0034605 | cellular response to heat | 3.32e-02 | 1.00e+00 | 4.889 | 1 | 1 | 29 |
GO:0072686 | mitotic spindle | 3.32e-02 | 1.00e+00 | 4.889 | 1 | 1 | 29 |
GO:0031647 | regulation of protein stability | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 30 |
GO:0007346 | regulation of mitotic cell cycle | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 3 | 30 |
GO:0040018 | positive regulation of multicellular organism growth | 3.44e-02 | 1.00e+00 | 4.840 | 1 | 1 | 30 |
GO:0043025 | neuronal cell body | 3.47e-02 | 1.00e+00 | 2.758 | 2 | 5 | 254 |
GO:0007093 | mitotic cell cycle checkpoint | 3.55e-02 | 1.00e+00 | 4.792 | 1 | 2 | 31 |
GO:0061077 | chaperone-mediated protein folding | 3.55e-02 | 1.00e+00 | 4.792 | 1 | 1 | 31 |
GO:0007528 | neuromuscular junction development | 3.66e-02 | 1.00e+00 | 4.747 | 1 | 1 | 32 |
GO:0051219 | phosphoprotein binding | 3.66e-02 | 1.00e+00 | 4.747 | 1 | 4 | 32 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 3.77e-02 | 1.00e+00 | 4.702 | 1 | 2 | 33 |
GO:0070830 | tight junction assembly | 3.77e-02 | 1.00e+00 | 4.702 | 1 | 1 | 33 |
GO:0001569 | patterning of blood vessels | 3.89e-02 | 1.00e+00 | 4.659 | 1 | 1 | 34 |
GO:0042692 | muscle cell differentiation | 3.89e-02 | 1.00e+00 | 4.659 | 1 | 2 | 34 |
GO:0016592 | mediator complex | 4.00e-02 | 1.00e+00 | 4.617 | 1 | 2 | 35 |
GO:0048666 | neuron development | 4.00e-02 | 1.00e+00 | 4.617 | 1 | 1 | 35 |
GO:0071333 | cellular response to glucose stimulus | 4.00e-02 | 1.00e+00 | 4.617 | 1 | 2 | 35 |
GO:0009725 | response to hormone | 4.00e-02 | 1.00e+00 | 4.617 | 1 | 1 | 35 |
GO:0003779 | actin binding | 4.01e-02 | 1.00e+00 | 2.643 | 2 | 3 | 275 |
GO:0051402 | neuron apoptotic process | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 1 | 36 |
GO:0001895 | retina homeostasis | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 1 | 36 |
GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway | 4.11e-02 | 1.00e+00 | 4.577 | 1 | 3 | 36 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 4.22e-02 | 1.00e+00 | 4.537 | 1 | 1 | 37 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.22e-02 | 1.00e+00 | 4.537 | 1 | 2 | 37 |
GO:0005791 | rough endoplasmic reticulum | 4.22e-02 | 1.00e+00 | 4.537 | 1 | 1 | 37 |
GO:0030049 | muscle filament sliding | 4.33e-02 | 1.00e+00 | 4.499 | 1 | 2 | 38 |
GO:0045740 | positive regulation of DNA replication | 4.33e-02 | 1.00e+00 | 4.499 | 1 | 1 | 38 |
GO:0070527 | platelet aggregation | 4.33e-02 | 1.00e+00 | 4.499 | 1 | 1 | 38 |
GO:0050681 | androgen receptor binding | 4.33e-02 | 1.00e+00 | 4.499 | 1 | 2 | 38 |
GO:0021766 | hippocampus development | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 3 | 39 |
GO:0031490 | chromatin DNA binding | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 39 |
GO:0060048 | cardiac muscle contraction | 4.45e-02 | 1.00e+00 | 4.461 | 1 | 1 | 39 |
GO:0001228 | RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 4.56e-02 | 1.00e+00 | 4.425 | 1 | 1 | 40 |
GO:0051117 | ATPase binding | 4.67e-02 | 1.00e+00 | 4.389 | 1 | 2 | 41 |
GO:0008307 | structural constituent of muscle | 4.67e-02 | 1.00e+00 | 4.389 | 1 | 1 | 41 |
GO:0030521 | androgen receptor signaling pathway | 4.67e-02 | 1.00e+00 | 4.389 | 1 | 3 | 41 |
GO:0035914 | skeletal muscle cell differentiation | 4.78e-02 | 1.00e+00 | 4.354 | 1 | 1 | 42 |
GO:0030155 | regulation of cell adhesion | 4.78e-02 | 1.00e+00 | 4.354 | 1 | 1 | 42 |
GO:0001047 | core promoter binding | 5.22e-02 | 1.00e+00 | 4.223 | 1 | 1 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 5.22e-02 | 1.00e+00 | 4.223 | 1 | 2 | 46 |
GO:0031594 | neuromuscular junction | 5.22e-02 | 1.00e+00 | 4.223 | 1 | 1 | 46 |
GO:0019901 | protein kinase binding | 5.26e-02 | 1.00e+00 | 2.425 | 2 | 9 | 320 |
GO:0008344 | adult locomotory behavior | 5.33e-02 | 1.00e+00 | 4.192 | 1 | 2 | 47 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 5.38e-02 | 1.00e+00 | 1.785 | 3 | 9 | 748 |
GO:0007411 | axon guidance | 5.47e-02 | 1.00e+00 | 2.393 | 2 | 3 | 327 |
GO:0001947 | heart looping | 5.56e-02 | 1.00e+00 | 4.132 | 1 | 1 | 49 |
GO:0043231 | intracellular membrane-bounded organelle | 5.62e-02 | 1.00e+00 | 2.371 | 2 | 3 | 332 |
GO:0007030 | Golgi organization | 5.67e-02 | 1.00e+00 | 4.103 | 1 | 3 | 50 |
GO:0034097 | response to cytokine | 5.67e-02 | 1.00e+00 | 4.103 | 1 | 1 | 50 |
GO:0001948 | glycoprotein binding | 5.67e-02 | 1.00e+00 | 4.103 | 1 | 2 | 50 |
GO:0006952 | defense response | 6.00e-02 | 1.00e+00 | 4.019 | 1 | 1 | 53 |
GO:0070062 | extracellular vesicular exosome | 6.00e-02 | 1.00e+00 | 1.035 | 6 | 51 | 2516 |
GO:0019900 | kinase binding | 6.11e-02 | 1.00e+00 | 3.992 | 1 | 3 | 54 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 6.11e-02 | 1.00e+00 | 3.992 | 1 | 1 | 54 |
GO:0050680 | negative regulation of epithelial cell proliferation | 6.11e-02 | 1.00e+00 | 3.992 | 1 | 1 | 54 |
GO:0046330 | positive regulation of JNK cascade | 6.22e-02 | 1.00e+00 | 3.965 | 1 | 1 | 55 |
GO:0030054 | cell junction | 6.36e-02 | 1.00e+00 | 2.271 | 2 | 4 | 356 |
GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment | 6.43e-02 | 1.00e+00 | 3.914 | 1 | 1 | 57 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 6.55e-02 | 1.00e+00 | 1.668 | 3 | 11 | 811 |
GO:0005840 | ribosome | 6.65e-02 | 1.00e+00 | 3.864 | 1 | 10 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 6.65e-02 | 1.00e+00 | 3.864 | 1 | 1 | 59 |
GO:0045216 | cell-cell junction organization | 6.65e-02 | 1.00e+00 | 3.864 | 1 | 2 | 59 |
GO:0010976 | positive regulation of neuron projection development | 6.76e-02 | 1.00e+00 | 3.840 | 1 | 2 | 60 |
GO:0005925 | focal adhesion | 6.80e-02 | 1.00e+00 | 2.215 | 2 | 23 | 370 |
GO:0003705 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity | 6.87e-02 | 1.00e+00 | 3.816 | 1 | 1 | 61 |
GO:0033138 | positive regulation of peptidyl-serine phosphorylation | 6.87e-02 | 1.00e+00 | 3.816 | 1 | 1 | 61 |
GO:0001078 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription | 6.98e-02 | 1.00e+00 | 3.792 | 1 | 1 | 62 |
GO:0006469 | negative regulation of protein kinase activity | 7.31e-02 | 1.00e+00 | 3.724 | 1 | 1 | 65 |
GO:0009636 | response to toxic substance | 7.41e-02 | 1.00e+00 | 3.702 | 1 | 1 | 66 |
GO:0071260 | cellular response to mechanical stimulus | 7.41e-02 | 1.00e+00 | 3.702 | 1 | 3 | 66 |
GO:0031295 | T cell costimulation | 7.52e-02 | 1.00e+00 | 3.680 | 1 | 3 | 67 |
GO:0030141 | secretory granule | 7.52e-02 | 1.00e+00 | 3.680 | 1 | 2 | 67 |
GO:0006338 | chromatin remodeling | 7.63e-02 | 1.00e+00 | 3.659 | 1 | 2 | 68 |
GO:0045666 | positive regulation of neuron differentiation | 7.63e-02 | 1.00e+00 | 3.659 | 1 | 1 | 68 |
GO:0035264 | multicellular organism growth | 7.85e-02 | 1.00e+00 | 3.617 | 1 | 1 | 70 |
GO:0034329 | cell junction assembly | 7.95e-02 | 1.00e+00 | 3.597 | 1 | 2 | 71 |
GO:0000785 | chromatin | 8.17e-02 | 1.00e+00 | 3.557 | 1 | 2 | 73 |
GO:0060070 | canonical Wnt signaling pathway | 8.38e-02 | 1.00e+00 | 3.518 | 1 | 2 | 75 |
GO:0007265 | Ras protein signal transduction | 8.38e-02 | 1.00e+00 | 3.518 | 1 | 3 | 75 |
GO:0044325 | ion channel binding | 8.60e-02 | 1.00e+00 | 3.480 | 1 | 3 | 77 |
GO:0010629 | negative regulation of gene expression | 8.92e-02 | 1.00e+00 | 3.425 | 1 | 2 | 80 |
GO:0045177 | apical part of cell | 9.13e-02 | 1.00e+00 | 3.389 | 1 | 1 | 82 |
GO:0030336 | negative regulation of cell migration | 9.24e-02 | 1.00e+00 | 3.371 | 1 | 2 | 83 |
GO:0007517 | muscle organ development | 9.24e-02 | 1.00e+00 | 3.371 | 1 | 1 | 83 |
GO:0043197 | dendritic spine | 9.24e-02 | 1.00e+00 | 3.371 | 1 | 2 | 83 |
GO:0005179 | hormone activity | 9.34e-02 | 1.00e+00 | 3.354 | 1 | 1 | 84 |
GO:0007160 | cell-matrix adhesion | 9.77e-02 | 1.00e+00 | 3.287 | 1 | 1 | 88 |
GO:0006936 | muscle contraction | 9.77e-02 | 1.00e+00 | 3.287 | 1 | 1 | 88 |
GO:0007596 | blood coagulation | 1.00e-01 | 1.00e+00 | 1.889 | 2 | 5 | 464 |
GO:0018279 | protein N-linked glycosylation via asparagine | 1.01e-01 | 1.00e+00 | 3.239 | 1 | 1 | 91 |
GO:0016605 | PML body | 1.02e-01 | 1.00e+00 | 3.223 | 1 | 2 | 92 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.02e-01 | 1.00e+00 | 3.223 | 1 | 3 | 92 |
GO:0042470 | melanosome | 1.02e-01 | 1.00e+00 | 3.223 | 1 | 2 | 92 |
GO:0006928 | cellular component movement | 1.02e-01 | 1.00e+00 | 3.223 | 1 | 4 | 92 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 1.03e-01 | 1.00e+00 | 3.207 | 1 | 1 | 93 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.04e-01 | 1.00e+00 | 3.192 | 1 | 7 | 94 |
GO:0051082 | unfolded protein binding | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 1 | 95 |
GO:0030165 | PDZ domain binding | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 1 | 95 |
GO:0001764 | neuron migration | 1.06e-01 | 1.00e+00 | 3.162 | 1 | 2 | 96 |
GO:0042802 | identical protein binding | 1.10e-01 | 1.00e+00 | 1.807 | 2 | 4 | 491 |
GO:0044267 | cellular protein metabolic process | 1.12e-01 | 1.00e+00 | 1.795 | 2 | 29 | 495 |
GO:0004888 | transmembrane signaling receptor activity | 1.13e-01 | 1.00e+00 | 3.060 | 1 | 1 | 103 |
GO:0014069 | postsynaptic density | 1.17e-01 | 1.00e+00 | 3.019 | 1 | 3 | 106 |
GO:0030496 | midbody | 1.20e-01 | 1.00e+00 | 2.978 | 1 | 4 | 109 |
GO:0005815 | microtubule organizing center | 1.21e-01 | 1.00e+00 | 2.965 | 1 | 4 | 110 |
GO:0030529 | ribonucleoprotein complex | 1.25e-01 | 1.00e+00 | 2.914 | 1 | 8 | 114 |
GO:0005819 | spindle | 1.25e-01 | 1.00e+00 | 2.914 | 1 | 4 | 114 |
GO:0072562 | blood microparticle | 1.27e-01 | 1.00e+00 | 2.889 | 1 | 1 | 116 |
GO:0016032 | viral process | 1.29e-01 | 1.00e+00 | 1.670 | 2 | 37 | 540 |
GO:0005654 | nucleoplasm | 1.31e-01 | 1.00e+00 | 1.235 | 3 | 26 | 1095 |
GO:0032496 | response to lipopolysaccharide | 1.33e-01 | 1.00e+00 | 2.816 | 1 | 1 | 122 |
GO:0006325 | chromatin organization | 1.34e-01 | 1.00e+00 | 2.804 | 1 | 2 | 123 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 1.34e-01 | 1.00e+00 | 2.804 | 1 | 3 | 123 |
GO:0007568 | aging | 1.34e-01 | 1.00e+00 | 2.804 | 1 | 2 | 123 |
GO:0007050 | cell cycle arrest | 1.37e-01 | 1.00e+00 | 2.769 | 1 | 2 | 126 |
GO:0030036 | actin cytoskeleton organization | 1.40e-01 | 1.00e+00 | 2.735 | 1 | 3 | 129 |
GO:0046983 | protein dimerization activity | 1.42e-01 | 1.00e+00 | 2.713 | 1 | 3 | 131 |
GO:0005509 | calcium ion binding | 1.49e-01 | 1.00e+00 | 1.544 | 2 | 4 | 589 |
GO:0003735 | structural constituent of ribosome | 1.52e-01 | 1.00e+00 | 2.607 | 1 | 24 | 141 |
GO:0007507 | heart development | 1.52e-01 | 1.00e+00 | 2.607 | 1 | 1 | 141 |
GO:0005911 | cell-cell junction | 1.53e-01 | 1.00e+00 | 2.597 | 1 | 2 | 142 |
GO:0005783 | endoplasmic reticulum | 1.57e-01 | 1.00e+00 | 1.494 | 2 | 6 | 610 |
GO:0045087 | innate immune response | 1.60e-01 | 1.00e+00 | 1.480 | 2 | 11 | 616 |
GO:0010628 | positive regulation of gene expression | 1.60e-01 | 1.00e+00 | 2.527 | 1 | 4 | 149 |
GO:0001666 | response to hypoxia | 1.61e-01 | 1.00e+00 | 2.518 | 1 | 1 | 150 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.61e-01 | 1.00e+00 | 2.518 | 1 | 11 | 150 |
GO:0030246 | carbohydrate binding | 1.62e-01 | 1.00e+00 | 2.508 | 1 | 1 | 151 |
GO:0042981 | regulation of apoptotic process | 1.62e-01 | 1.00e+00 | 2.508 | 1 | 7 | 151 |
GO:0001077 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription | 1.62e-01 | 1.00e+00 | 2.508 | 1 | 2 | 151 |
GO:0005788 | endoplasmic reticulum lumen | 1.68e-01 | 1.00e+00 | 2.452 | 1 | 2 | 157 |
GO:0043005 | neuron projection | 1.72e-01 | 1.00e+00 | 2.416 | 1 | 6 | 161 |
GO:0045121 | membrane raft | 1.72e-01 | 1.00e+00 | 2.416 | 1 | 3 | 161 |
GO:0005516 | calmodulin binding | 1.73e-01 | 1.00e+00 | 2.407 | 1 | 3 | 162 |
GO:0005794 | Golgi apparatus | 1.74e-01 | 1.00e+00 | 1.402 | 2 | 8 | 650 |
GO:0031625 | ubiquitin protein ligase binding | 1.90e-01 | 1.00e+00 | 2.255 | 1 | 4 | 180 |
GO:0043687 | post-translational protein modification | 1.91e-01 | 1.00e+00 | 2.247 | 1 | 1 | 181 |
GO:0015629 | actin cytoskeleton | 1.93e-01 | 1.00e+00 | 2.231 | 1 | 3 | 183 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.94e-01 | 1.00e+00 | 2.223 | 1 | 5 | 184 |
GO:0007173 | epidermal growth factor receptor signaling pathway | 2.01e-01 | 1.00e+00 | 2.169 | 1 | 5 | 191 |
GO:0003924 | GTPase activity | 2.12e-01 | 1.00e+00 | 2.081 | 1 | 6 | 203 |
GO:0030168 | platelet activation | 2.14e-01 | 1.00e+00 | 2.067 | 1 | 4 | 205 |
GO:0005886 | plasma membrane | 2.24e-01 | 1.00e+00 | 0.600 | 5 | 24 | 2834 |
GO:0006184 | GTP catabolic process | 2.27e-01 | 1.00e+00 | 1.965 | 1 | 6 | 220 |
GO:0005622 | intracellular | 2.33e-01 | 1.00e+00 | 1.926 | 1 | 1 | 226 |
GO:0006412 | translation | 2.41e-01 | 1.00e+00 | 1.870 | 1 | 29 | 235 |
GO:0003713 | transcription coactivator activity | 2.45e-01 | 1.00e+00 | 1.846 | 1 | 6 | 239 |
GO:0007399 | nervous system development | 2.50e-01 | 1.00e+00 | 1.810 | 1 | 1 | 245 |
GO:0043065 | positive regulation of apoptotic process | 2.75e-01 | 1.00e+00 | 1.648 | 1 | 6 | 274 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 2.76e-01 | 1.00e+00 | 1.643 | 1 | 2 | 275 |
GO:0007283 | spermatogenesis | 2.77e-01 | 1.00e+00 | 1.638 | 1 | 2 | 276 |
GO:0006351 | transcription, DNA-templated | 2.79e-01 | 1.00e+00 | 0.701 | 3 | 17 | 1585 |
GO:0007264 | small GTPase mediated signal transduction | 2.89e-01 | 1.00e+00 | 1.567 | 1 | 7 | 290 |
GO:0030198 | extracellular matrix organization | 2.93e-01 | 1.00e+00 | 1.542 | 1 | 1 | 295 |
GO:0016567 | protein ubiquitination | 2.96e-01 | 1.00e+00 | 1.523 | 1 | 3 | 299 |
GO:0030154 | cell differentiation | 3.18e-01 | 1.00e+00 | 1.402 | 1 | 3 | 325 |
GO:0005525 | GTP binding | 3.20e-01 | 1.00e+00 | 1.389 | 1 | 6 | 328 |
GO:0003682 | chromatin binding | 3.25e-01 | 1.00e+00 | 1.363 | 1 | 4 | 334 |
GO:0005615 | extracellular space | 3.31e-01 | 1.00e+00 | 0.766 | 2 | 3 | 1010 |
GO:0000278 | mitotic cell cycle | 3.75e-01 | 1.00e+00 | 1.110 | 1 | 16 | 398 |
GO:0009986 | cell surface | 3.92e-01 | 1.00e+00 | 1.025 | 1 | 1 | 422 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.94e-01 | 1.00e+00 | 1.019 | 1 | 2 | 424 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.94e-01 | 1.00e+00 | 1.015 | 1 | 3 | 425 |
GO:0006468 | protein phosphorylation | 4.24e-01 | 1.00e+00 | 0.879 | 1 | 6 | 467 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.38e-01 | 1.00e+00 | 0.819 | 1 | 8 | 487 |
GO:0048471 | perinuclear region of cytoplasm | 4.62e-01 | 1.00e+00 | 0.716 | 1 | 9 | 523 |
GO:0003677 | DNA binding | 4.74e-01 | 1.00e+00 | 0.347 | 2 | 14 | 1351 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 5.03e-01 | 1.00e+00 | 0.544 | 1 | 9 | 589 |
GO:0005634 | nucleus | 5.10e-01 | 1.00e+00 | 0.094 | 6 | 66 | 4828 |
GO:0042803 | protein homodimerization activity | 5.19e-01 | 1.00e+00 | 0.477 | 1 | 4 | 617 |
GO:0005789 | endoplasmic reticulum membrane | 5.30e-01 | 1.00e+00 | 0.434 | 1 | 3 | 636 |
GO:0010467 | gene expression | 5.49e-01 | 1.00e+00 | 0.361 | 1 | 36 | 669 |
GO:0007165 | signal transduction | 6.80e-01 | 1.00e+00 | -0.145 | 1 | 7 | 950 |
GO:0008270 | zinc ion binding | 7.23e-01 | 1.00e+00 | -0.313 | 1 | 7 | 1067 |
GO:0006355 | regulation of transcription, DNA-templated | 7.36e-01 | 1.00e+00 | -0.362 | 1 | 10 | 1104 |
GO:0005524 | ATP binding | 8.07e-01 | 1.00e+00 | -0.656 | 1 | 19 | 1354 |
GO:0005730 | nucleolus | 8.74e-01 | 1.00e+00 | -0.971 | 1 | 36 | 1684 |
GO:0016021 | integral component of membrane | 9.57e-01 | 1.00e+00 | -1.531 | 1 | 4 | 2483 |